Effects of EDUcation and EXercise Compared to Education Alone on Clinical and Physiological Outcomes in Patients With Hip Osteoarthritis
Launched by UNIVERSITY OF AARHUS · Apr 25, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The EDUEX trial is studying how adding exercise to a patient education program can help people with hip osteoarthritis (OA). Specifically, the trial will compare the effects of a program that includes progressive resistance training (which means gradually increasing weights or resistance during exercise) alongside education about managing hip OA, versus education alone. The goal is to see if those who participate in both exercise and education experience less pain and improved function compared to those who only receive education.
To be eligible for this trial, participants must be at least 45 years old, have a confirmed diagnosis of hip OA, and experience daily hip pain. They should not be planning to have hip replacement surgery in the next year or have certain other health conditions that could affect their hip function. Throughout the trial, participants will be monitored over 12 months to assess their progress. This study is open to anyone regardless of gender, and it aims to recruit 150 people from various sources, including hospitals and social media. If you join, you can expect to take part in assessments that will help researchers understand how exercise affects hip joint health and pain relief.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinically diagnosed with hip OA according to the criteria by the National Institute for Health and Care Excellence (NICE)
- • Radiographic verification of hip OA diagnosis with Kellgren Lawrence score of 2 or 3 in one or both hips
- • Not scheduled for a total hip replacement within the following 12 months
- • An event of hip pain every day of at least 3 out of 10 on a numerical rating scale during the last 14 days
- • Age ≥ 45 years
- • Adequacy in written and spoken Danish
- Exclusion Criteria:
- • Comorbidity that markedly influences hip function or degeneration of tissue in or around the hip joint (rheumatic, neurological, mental or other)
- • Surgery in the lower extremities within the six months prior to inclusion
- • BMI \> 40
- • Pregnancy
- • Resistance exercise (weights or elastic bands) for the lower extremities exceeding 12 sessions over the last 6 months or 6 sessions over the last 3 months
- • Suffering from claustrophobia or not tolerating whole body MRI scanner
- • Metallic implants from the waist to just above the knee
- • Pacemaker or other medical devices that are not MR approved
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus N, , Denmark
Aarhus C, , Denmark
Patients applied
Trial Officials
Troels Kjeldsen, MSc
Principal Investigator
Aarhus University Hospital
Thomas Frydendal, PhD
Principal Investigator
Aarhus University Hospital
Inger Mechlenburg, Prof.
Study Director
Aarhus University Hospital
Ulrik Dalgas, Prof.
Study Director
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported